anmelden
BX Swiss TOP 30 CHF
1.488,58
PKT
+8,29
PKT
+0,56
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 29.09.14 | UBS Underweight | JP Morgan Chase & Co. | |
| 29.09.14 | UBS Hold | Commerzbank AG | |
| 29.09.14 | UBS overweight | JP Morgan Chase & Co. | |
| 29.09.14 | Roche buy | UBS AG | |
| 26.09.14 | Roche overweight | Morgan Stanley | |
| 26.09.14 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.09.14 | Holcim buy | Deutsche Bank AG | |
| 24.09.14 | Holcim buy | Deutsche Bank AG | |
| 22.09.14 | Swiss Re Underperform | BNP PARIBAS | |
| 19.09.14 | Roche buy | Deutsche Bank AG | |
| 19.09.14 | Novartis Hold | Deutsche Bank AG | |
| 19.09.14 | Swiss Re buy | Deutsche Bank AG | |
| 18.09.14 | Givaudan buy | Nomura | |
| 18.09.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 18.09.14 | Holcim buy | UBS AG | |
| 18.09.14 | Holcim buy | UBS AG | |
| 17.09.14 | Nestlé Hold | Société Générale Group S.A. (SG) | |
| 16.09.14 | Roche kaufen | Independent Research GmbH | |
| 16.09.14 | Novartis Underweight | Morgan Stanley | |
| 16.09.14 | Roche overweight | Morgan Stanley | |
| 15.09.14 | Novartis buy | Jefferies & Company Inc. | |
| 15.09.14 | Roche buy | Jefferies & Company Inc. | |
| 15.09.14 | UBS Equal weight | Barclays Capital | |
| 12.09.14 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 11.09.14 | Holcim overweight | JP Morgan Chase & Co. | |
| 11.09.14 | Roche overweight | JP Morgan Chase & Co. | |
| 11.09.14 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.09.14 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.09.14 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 10.09.14 | ABB (Asea Brown Boveri) overweight | Morgan Stanley | |
| 10.09.14 | Zurich Insurance neutral | Jefferies & Company Inc. | |
| 10.09.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.09.14 | UBS Underweight | JP Morgan Chase & Co. | |
| 10.09.14 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 10.09.14 | UBS overweight | JP Morgan Chase & Co. | |
| 09.09.14 | Swiss Re Underweight | JP Morgan Chase & Co. | |
| 09.09.14 | Swiss Re buy | Deutsche Bank AG | |
| 09.09.14 | UBS buy | Deutsche Bank AG | |
| 09.09.14 | Novartis overweight | JP Morgan Chase & Co. | |
| 09.09.14 | Swiss Re Underperform | Credit Suisse Group |